CAS 204656-20-2

(4S)-5-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-il)propanoyl]amino]propanoyl]amino]-5-hid...

Descrição:

A substância química com o nome "(4S)-5-[[[5S)-5-[[[2S)-2-[[[2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-5-hid" e o número CAS "204656-20-2" é um peptídeo complexo com múltiplos estereocentros, indicando que provavelmente exibirá quiralidade, o que pode influenciar sua atividade biológica e interações. Esta substância é caracterizada por uma série de resíduos de aminoácidos, incluindo imidazol, o que sugere papéis potenciais em sistemas biológicos, possivelmente como uma molécula sinalizadora ou na catálise enzimática. A presença de múltiplos grupos amino e funcionalidades de ácido carboxílico indica que pode ter uma solubilidade significativa em solventes polares e poderia participar de várias reações bioquímicas. Sua estrutura intrincada também pode sugerir propriedades conformacionais específicas que são cruciais para sua função em contextos biológicos. No geral, este composto exemplifica a complexidade frequentemente encontrada em peptídeos e proteínas biologicamente ativos.

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

InChI: InChI=1/C172H265N43O51/c1-18-20-21-22-23-24-25-26-27-28-29-30-37-53-128(223)193-112(59-64-132(227)228)148(244)180-68-41-40-50-111(154(250)199-116(62-67-135(233)234)155(251)204-120(73-100-44-33-31-34-45-100)160(256)214-140(93(11)19-2)168(264)192-97(15)146(242)201-122(76-103-79-183-108-49-39-38-48-106(103)108)158(254)203-118(72-90(5)6)159(255)212-138(91(7)8)166(262)200-110(52-43-70-182-172(177)178)150(246)184-81-129(224)194-109(51-42-69-181-171(175)176)149(245)187-84-137(237)238)196-144(240)95(13)189-143(239)94(12)191-153(249)115(58-63-127(174)222)195-130(225)82-185-152(248)114(61-66-134(231)232)198-156(252)117(71-89(3)4)202-157(253)119(75-102-54-56-105(221)57-55-102)205-163(259)124(85-216)208-165(261)126(87-218)209-167(263)139(92(9)10)213-162(258)123(78-136(235)236)206-164(260)125(86-217)210-170(266)142(99(17)220)215-161(257)121(74-101-46-35-32-36-47-101)207-169(265)141(98(16)219)211-131(226)83-186-151(247)113(60-65-133(229)230)197-145(241)96(14)190-147(243)107(173)77-104-80-179-88-188-104/h31-36,38-39,44-49,54-57,79-80,88-99,107,109-126,138-142,183,216-221H,18-30,37,40-43,50-53,58-78,81-87,173H2,1-17H3,(H2,174,222)(H,179,188)(H,180,244)(H,184,246)(H,185,248)(H,186,247)(H,187,245)(H,189,239)(H,190,243)(H,191,249)(H,192,264)(H,193,223)(H,194,224)(H,195,225)(H,196,240)(H,197,241)(H,198,252)(H,199,250)(H,200,262)(H,201,242)(H,202,253)(H,203,254)(H,204,251)(H,205,259)(H,206,260)(H,207,265)(H,208,261)(H,209,263)(H,210,266)(H,211,226)(H,212,255)(H,213,258)(H,214,256)(H,215,257)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H,235,236)(H,237,238)(H4,175,176,181)(H4,177,178,182)/t93-,94-,95-,96-,97-,98+,99+,107-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,138-,139-,140-,141-,142-/m0/s1

Sinónimos:

• Liraglutida [INN-Spanish]
• Liraglutide
• Liraglutidum [INN-Latin]
• Nn 2211
• Nn2211
• Unii-839I73S42A
• Liraglutide [usan:inn]
• Liroglutide
• N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide
• Liraglutide /Liraglutide Acetate
• Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-
• HAEGTFTSDVSSYLEGQAAK [N-(1-oxohexadecyl)-L-γ-glutaMyl] EFI AWLVRGRG
• (Lys(g-Glu-palMitoyl)26,Arg34)-GLP-1 (7-37)
• Liraglutida
• Liraglutide, (Lys(γ-Glu-palmitoyl)26,Arg34)-GLP-1 (7-37)
• (Lys(γ-Glu-palMitoyl)26,Arg34)-GLP-1 (7-37)
• H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(g-Glu-palMitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
• Liraglutidum
• Liraglutide Impurity
• Liraglutide injection
• Liraglutide, NN2211
• NNC 90-1170
• N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide
• Victoza

Liraglutide

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: 99%

Cor e Forma: Solid

Peso molecular: 3751.2020

Ref: IN-DA003RAK

Liraglutide-d8 Tetratrifluoroacetate

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₅₇D₈N₄₃O₅₁·4C₂HF₃O₂

Peso molecular: 3759.31 4*114.02

Ref: 4Z-PL-105047

Liraglutide

CAS: 204656-20-2

Liraglutide

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Cor e Forma: Solid

Peso molecular: 3751.0

Ref: 54-BI9895

Liraglutide-d8 Tritrifluoroacetate

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₅₇D₈N₄₃O₅₁·3C₂HF₃O₂

Cor e Forma: White To Off-White Solid

Peso molecular: 3759.31 3*114.02

Ref: 4Z-PL-105002

Liraglutide

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Cor e Forma: White To Off-White Solid

Peso molecular: 3751.26

Ref: 4Z-PL-105001

Liraglutide

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: 95%~99%

Cor e Forma: White to Off-white Powder

Peso molecular: 3751. 20

Ref: BP-BPPG046

Liraglutide

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: ≥ 98.0%

Cor e Forma: White to off-white powder

Peso molecular: 3751.2

Ref: 7W-GX3695

Liraglutide

CAS: 204656-20-2

Liraglutide (Liraglutida) is a synthetic analog of GLP-1, an agonist of the GLP-1 receptor. Liraglutide is an antidiabetic agent. Cost effective and quality assured.

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: 97.65% - 99.04%

Cor e Forma: White Solid

Peso molecular: 3751.25

Ref: TM-T6876

Liraglutide

Produto Controlado

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Cor e Forma: Neat

Peso molecular: 3751.2

Ref: TR-L468860

Liraglutide sodium

CAS: 204656-20-2

Please enquire for more information about Liraglutide sodium  including the price, delivery time and more detailed product information at the technical inquiry form on this page

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁•(Na)x

Ref: 3D-BL184581

Liraglutide acetate

CAS: 204656-20-2

Liraglutide is a glucagon-like peptide-1 analog that has been shown to be an effective treatment for obesity. Liraglutide targets the adipose tissue and reduces the amount of glucose in the blood by increasing insulin sensitivity, lowering food intake, and reducing appetite. In addition, Liraglutide has been shown to suppress postprandial hyperglycemia and lower plasma glucose levels in patients with type 2 diabetes mellitus. Liraglutide also inhibits neuronal death induced by apoptotic stimuli, which may have potential use as a model system for neurodegenerative diseases such as Parkinson's disease. Liraglutide has also been shown to be an effective therapy for infectious diseases including Crohn's disease and ulcerative colitis. This drug has shown some effectiveness against atherosclerosis in animal models by inducing apoptosis in macrophages that are associated with lesions.

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: Min. 95%

Peso molecular: 3,751.29 g/mol

Ref: 3D-PGL-3781-PI

Liraglutide

CAS: 204656-20-2

Glucagon-like peptide 1 (GLP-1) receptor agonist; hypoglycemic agent

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: Min. 95 Area-%

Cor e Forma: White Powder

Peso molecular: 3,751.2 g/mol

Ref: 3D-FL109949

Liraglutide

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Peso molecular: 3751.26

Ref: ST-EA-CP-L86000

Liraglutide trifluoroacetate salt

CAS: 204656-20-2

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist and used to treat diabetes mellitus type 2 and obesity. The GLP-1 receptor agonists stimulate insulin secretion and inhibit glucagon secretion.

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: 98.9%

Peso molecular: 3751.26

Ref: 01-4041752